Literature DB >> 19225847

Antiviral and antibiotic prescribing for influenza in primary care.

Jeffrey A Linder1, Harry Reyes Nieva, William A Blumentals.   

Abstract

BACKGROUND: Anti-influenza antiviral medications reduce influenza-related morbidity, but may often be used inappropriately.
OBJECTIVE: To measure the rate of antiviral and antibiotic prescribing, the appropriateness of antiviral prescribing, and evaluate independent predictors of antiviral and antibiotic prescribing for influenza in primary care. DESIGN AND PATIENTS: Retrospective analysis of 958 visits of clinician-diagnosed influenza in 21 primary care clinics in eastern Massachusetts from 1999 to 2007. We considered antiviral prescribing appropriate if patients had symptoms for 2 or fewer days, had fever, and any 2 of headache, sore throat, cough, or myalgias.
MEASUREMENTS AND MAIN RESULTS: Clinicians prescribed antivirals in 557 (58%) visits and antibiotics in 104 visits (11%). Of antiviral prescriptions, 38% were not appropriate, most commonly because of symptoms for more than 2 days (24% of antiviral prescriptions). In multivariate modeling, selected independent predictors of antiviral prescribing were symptom duration of 2 or fewer days (odds ratio [OR], 12.4; 95% confidence interval [CI], 8.3 to 18.6), year (OR, 1.4 for each successive influenza season; 95% CI, 1.3 to 1.7), patient age (OR, 1.3 per decade; 95% CI, 1.2 to 1.5), and, compared to having no influenza testing, having a negative influenza test (OR, 5.5; 95% CI, 3.4 to 9.1) or a positive influenza test (OR, 11.4; 95% CI, 6.7 to 19.3). Independent predictors of antibiotic prescribing included otoscopic abnormalities (OR, 3.3; 95% CI, 1.8 to 6.0), abnormal lung examination (OR, 4.0; 95% CI, 2.1 to 6.2), and having a chest x-ray performed (OR, 2.2; 95% CI, 1.3 to 3.8).
CONCLUSIONS: Primary care clinicians are much more likely to prescribe antivirals to patients with symptoms for 2 or fewer days, but also commonly prescribe antivirals inappropriately.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19225847      PMCID: PMC2659164          DOI: 10.1007/s11606-009-0933-9

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  26 in total

1.  Two neuraminidase inhibitors for treatment of influenza.

Authors: 
Journal:  Med Lett Drugs Ther       Date:  1999-10-08       Impact factor: 1.909

2.  A security architecture for query tools used to access large biomedical databases.

Authors:  Shawn N Murphy; Henry C Chueh
Journal:  Proc AMIA Symp       Date:  2002

Review 3.  Clinical practice. Prevention and treatment of seasonal influenza.

Authors:  W Paul Glezen
Journal:  N Engl J Med       Date:  2008-12-11       Impact factor: 91.245

4.  Cost associated with the treatment of influenza in a managed care setting.

Authors:  F Cox; Z M Khan; J E Schweinle; L Okamoto; T McLaughlin
Journal:  MedGenMed       Date:  2000-10-03

5.  Use of oseltamivir during influenza outbreaks in Ontario nursing homes, 1999-2000.

Authors:  Susan K Bowles; Wayne Lee; Andrew E Simor; Mary Vearncombe; Mark Loeb; Susan Tamblyn; Margaret Fearon; Yan Li; Allison McGeer
Journal:  J Am Geriatr Soc       Date:  2002-04       Impact factor: 5.562

6.  Diagnosis of influenza in the community: relationship of clinical diagnosis to confirmed virological, serologic, or molecular detection of influenza.

Authors:  M Zambon; J Hays; A Webster; R Newman; O Keene
Journal:  Arch Intern Med       Date:  2001-09-24

7.  Clinical signs and symptoms predicting influenza infection.

Authors:  A S Monto; S Gravenstein; M Elliott; M Colopy; J Schweinle
Journal:  Arch Intern Med       Date:  2000-11-27

8.  Zanamivir for the treatment of influenza A and B infection in high-risk patients: a pooled analysis of randomized controlled trials.

Authors:  J Lalezari; K Campion; O Keene; C Silagy
Journal:  Arch Intern Med       Date:  2001-01-22

9.  Management of influenza in adults older than 65 years of age: cost-effectiveness of rapid testing and antiviral therapy.

Authors:  Michael B Rothberg; Sandra Bellantonio; David N Rose
Journal:  Ann Intern Med       Date:  2003-09-02       Impact factor: 25.391

10.  The effect of zanamivir treatment on influenza complications: a retrospective cohort study.

Authors:  J Alexander Cole; Jeanne E Loughlin; Anuli N Ajene; Daniel M Rosenberg; Suzanne E Cook; Alexander M Walker
Journal:  Clin Ther       Date:  2002-11       Impact factor: 3.393

View more
  6 in total

1.  Respiratory viral testing: new frontiers in diagnostics and implications for antimicrobial stewardship.

Authors:  Russell J McCulloh; Michael Koster; Kimberle Chapin
Journal:  Virulence       Date:  2013-01-01       Impact factor: 5.882

2.  Influenza antiviral treatment in spinal cord injury patients, 2007-2010.

Authors:  Charlesnika T Evans; Thea J Rogers; Barry Goldstein; Frances M Weaver; Sherri L LaVela
Journal:  J Spinal Cord Med       Date:  2014-06-24       Impact factor: 1.985

3.  Are Rapid Influenza Antigen Tests Still Clinically Useful in Today's Molecular Diagnostics World?

Authors:  Valentina K Trombetta; Yvonne L Chan; Matthew J Bankowski
Journal:  Hawaii J Med Public Health       Date:  2018-09

4.  Influenza Antiviral Prescribing Practices and the Influence of Rapid Testing Among Primary Care Providers in the US, 2009-2016.

Authors:  Ashley L Fowlkes; Andrea Steffens; Carrie Reed; Jonathan L Temte; Angela P Campbell
Journal:  Open Forum Infect Dis       Date:  2019-04-26       Impact factor: 3.835

5.  Cost-effectiveness analysis of antiviral treatment in the management of seasonal influenza A: point-of-care rapid test versus clinical judgment.

Authors:  Léon Nshimyumukiza; Xavier Douville; Diane Fournier; Julie Duplantie; Rana K Daher; Isabelle Charlebois; Jean Longtin; Jesse Papenburg; Maryse Guay; Maurice Boissinot; Michel G Bergeron; Denis Boudreau; Christian Gagné; François Rousseau; Daniel Reinharz
Journal:  Influenza Other Respir Viruses       Date:  2016-01-29       Impact factor: 4.380

6.  Feasibility of Point-of-Care Testing for Influenza Within a National Primary Care Sentinel Surveillance Network in England: Protocol for a Mixed Methods Study.

Authors:  Simon de Lusignan; Uy Hoang; Harshana Liyanage; Ivelina Yonova; Filipa Ferreira; Javier Diez-Domingo; Tristan Clark
Journal:  JMIR Res Protoc       Date:  2019-11-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.